<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="3025">
  <stage>Registered</stage>
  <submitdate>15/12/2010</submitdate>
  <approvaldate>15/12/2010</approvaldate>
  <nctid>NCT01261611</nctid>
  <trial_identification>
    <studytitle>Study Comparing Short Term Efficacy of Dysport® and Dysport RU® to Placebo, and to Assess Efficacy and Safety of Dysport RU® of Subjects With Cervical Dystonia</studytitle>
    <scientifictitle>A Phase III, Randomised, Double-blind and Open Label Phase, Active and Placebo Controlled Study Comparing the Short Term Efficacy of Two Formulations of Clostridium Botulinum Type A Toxin (Dysport® and Dysport RU®) to Placebo, and Assessing the Short and Long Term Efficacy and Safety of Dysport RU® Following Repeated Treatments of Subjects With Cervical Dystonia</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>2010-019907-43</secondaryid>
    <secondaryid>Y-52-52120-134</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Cervical Dystonia</healthcondition>
    <conditioncode>
      <conditioncode1>Musculoskeletal</conditioncode1>
      <conditioncode2>Other muscular and skeletal disorders</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Neurological</conditioncode1>
      <conditioncode2>Other neurological disorders</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Human Genetics and Inherited Disorders</conditioncode1>
      <conditioncode2>Other human genetics and inherited disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Treatment: drugs - Botulinum type A toxin (Dysport RU®)
Treatment: drugs - Botulinum type A toxin (Dysport®)
Treatment: drugs - Placebo

Experimental: Dysport RU - 500U (1ml) administered as intramuscular injection on day 1 of treatment cycle 1 and 2.
250U (0.5ml), 500U (1ml) or 750U (1.5ml) administered as intramuscular injection on day 1 of treatment cycle 3.
250U (0.5ml), 500U (1ml), 750U (1.5ml) or 1000U (2ml) administered as intramuscular injection on day 1 of treatment cycle 4 and 5.

Active Comparator: Dysport - 500U (1ml) injected as intramuscular injection on day 1 of treatment cycle 1.

Placebo Comparator: Placebo - 1ml administered as, intramuscular injection on day 1 of treatment cycle 1.


Treatment: drugs: Botulinum type A toxin (Dysport RU®)
I.M. (in the muscle) injection on day 1 of up to 5 treatment cycles.

Treatment: drugs: Botulinum type A toxin (Dysport®)
I.M. injection on day 1 of treatment cycle 1.

Treatment: drugs: Placebo
I.M. injection on day 1 of treatment cycle 1.

</interventions>
    <comparator />
    <control />
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Change in Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) total score following first treatment</outcome>
      <timepoint>Baseline and Week 4</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Change in Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) severity score following first treatment</outcome>
      <timepoint>Baseline and Week 4</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Change in Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) disability score following first treatment</outcome>
      <timepoint>Baseline and Week 4</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Change in Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) pain sub-scale score following first treatment</outcome>
      <timepoint>Baseline and Week 4</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Change in Subject Visual Analogue Score (VAS) for pain from Cervical Dystonia following first treatment</outcome>
      <timepoint>Baseline and Week 4</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Change in Subject Visual Analogue Score (VAS) for symptoms of Cervical Dystonia following first treatment</outcome>
      <timepoint>Baseline and Week 4</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Proportion of treatment responders</outcome>
      <timepoint>Baseline and Week 4</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Change in Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) total score for treatment cycles 2 to 5</outcome>
      <timepoint>Treatment cycle Baseline and Week 4</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Change in Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) severity score for treatment cycles 2 to 5</outcome>
      <timepoint>Treatment cycle Baseline and Week 4</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Change in Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) disability score for treatment cycles 2 to 5</outcome>
      <timepoint>Treatment cycle Baseline and Week 4</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Change in Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) pain sub-scale score for treatment cycles 2 to 5</outcome>
      <timepoint>Treatment cycle Baseline and Week 4</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Change in Subject Visual Analogue Score (VAS) for pain from Cervical Dystonia for treatment cycles 2 to 5</outcome>
      <timepoint>Treatment cycle Baseline and Week 4</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Change in Subject Visual Analogue Score (VAS) for symptoms of Cervical Dystonia for treatment cycles 2 to 5</outcome>
      <timepoint>Treatment cycle Baseline and Week 4</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Proportion of treatment responders</outcome>
      <timepoint>Treatment cycle Baseline and Week 4</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>-  Dystonia with at least 18 months duration since onset.

          -  Previously untreated with Botulinum toxin-A (BTX-A) or -B or a minimum of 14 weeks
             since the last injection.

          -  TWSTRS score at baseline of: Total score = 30, Severity Sub-Scale score = 15,
             Disability Sub-Scale score = 3, Pain Sub-Scale score = 2.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage />
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>-  Known hypersensitivity to Botulinum toxin (BTX) or related compounds or any component
             in the study drug formulation (including cow milk protein).

          -  Pure anterocollis or pure retrocollis.

          -  In apparent remission from Cervical Dystonia.

          -  Known clinically significant underlying swallowing or respiratory abnormality which
             might be exacerbated by BTX treatment.

          -  Previous poor response to BTX treatment or known presence of BTX neutralising
             antibodies.

          -  Previous phenol or alcohol injections into the neck muscles.

          -  Previous myotomy or denervation surgery involving the neck or shoulder region.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1>The people receiving the treatment/s</masking1>
    <masking2>The people administering the treatment/s</masking2>
    <masking3>The people assessing the outcomes</masking3>
    <masking4>The people analysing the results/data</masking4>
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 3</phase>
    <anticipatedstartdate />
    <actualstartdate>1/04/2011</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize />
    <actualsamplesize>333</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate>1/05/2013</actuallastvisitdate>
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
    <hospital>Monash Medical Centre - Clayton</hospital>
    <hospital>Austin Hospital - Heidelberg</hospital>
    <hospital>Department of Neurosciences Alfred Hospital - Prahran</hospital>
    <hospital>Westmead Hospital - Westmead</hospital>
    <postcode> - Clayton</postcode>
    <postcode> - Heidelberg</postcode>
    <postcode> - Prahran</postcode>
    <postcode> - Westmead</postcode>
    <countryoutsideaustralia>
      <country>Austria</country>
      <state>Innsbruck</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Austria</country>
      <state>Wien</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Belgium</country>
      <state>Brugge</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Belgium</country>
      <state>Edegem</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Belgium</country>
      <state>Gent</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Belgium</country>
      <state>Liège</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Belgium</country>
      <state>Roeselare</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Czech Republic</country>
      <state>Brno</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Czech Republic</country>
      <state>Pardubice</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Czech Republic</country>
      <state>Plzen</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Czech Republic</country>
      <state>Praha</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>France</country>
      <state>Amiens</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>France</country>
      <state>Bron</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>France</country>
      <state>Nîmes</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>France</country>
      <state>Pessac</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>France</country>
      <state>Strasbourg</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>France</country>
      <state>Toulouse</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Germany</country>
      <state>Berlin</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Germany</country>
      <state>Bonn</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Germany</country>
      <state>Düsseldorf</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Germany</country>
      <state>Halle</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Germany</country>
      <state>Hannover</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Germany</country>
      <state>Leipzig</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Germany</country>
      <state>München</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Germany</country>
      <state>Tübingen</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Germany</country>
      <state>Wiesbaden</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Germany</country>
      <state>Würzburg</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Hungary</country>
      <state>Budapest</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Hungary</country>
      <state>Nyíregyháza</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Hungary</country>
      <state>Pécs</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Hungary</country>
      <state>Szeged</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Poland</country>
      <state>Gdansk</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Poland</country>
      <state>Katowice</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Poland</country>
      <state>Krakow</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Poland</country>
      <state>Lodz</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Poland</country>
      <state>Poznan</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Poland</country>
      <state>Warszawa</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Portugal</country>
      <state>Lisboa</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Portugal</country>
      <state>Porto</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Russian Federation</country>
      <state>Kazan</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Russian Federation</country>
      <state>Moscow</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Russian Federation</country>
      <state>Nizhniy Novgorod</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Russian Federation</country>
      <state>Samara</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Russian Federation</country>
      <state>Smolensk</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Russian Federation</country>
      <state>St. Petersburg</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Ukraine</country>
      <state>Chernivtsi</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Ukraine</country>
      <state>Dnipropetrovsk</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Ukraine</country>
      <state>Donetsk</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Ukraine</country>
      <state>Kharkiv</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Ukraine</country>
      <state>Lviv</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Ukraine</country>
      <state>Odessa</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Ukraine</country>
      <state>Uzhgorod</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Ukraine</country>
      <state>Vinnytsya</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Commercial sector/Commercial sector/Industry</primarysponsortype>
    <primarysponsorname>Ipsen</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
  </sponsorship>
  <ethicsAndSummary>
    <summary>The purpose of this study is to evaluate how well a new drug called Dysport RU works and how
      safe it is, when it is used for the treatment of cervical dystonia. Dysport RU will be
      compared to an approved drug called Dysport.</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT01261611</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Ipsen Study Director</name>
      <address>Ipsen</address>
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>